Clinical characterization of bipolar disorder in adults with autism without intellectual disability: a cross-sectional study.

This was an observational study — researchers watched what happened rather than assigning treatments. It can show that two things happen together, but it cannot show that one caused the other.

It involved 62 people — a modest group, enough to be interesting but not enough to settle a question on its own.

The researchers concluded: "BD in adults with ASD-noID presents a distinct clinical phenotype, characterized by atypical mood presentations, emotional dysregulation, complex comorbidity, and reduced treatment tolerability. These findings highlight the importance of improving diagnostic accuracy and adopting personalized treatment approaches for adults with this comorbidity."

This record does not state:

• the ages of the people who took part
• how long the study ran

This is a plain-language summary of one paper's abstract, not medical advice. Talk to your child's clinician before changing anything.

Journal: Journal of affective disorders

Year: 2026

Design: Observational Study

Participants: 62

Intervention: Bipolar disorder

Co-occurring conditions: Bipolar Disorder, Intellectual Disability

Authors: Margherita Barbuti, Salvatore Amadori, Ugo De Rosa, Giulio Perugi

OBJECTIVE: The present study aims to provide a detailed clinical characterization of adult patients with bipolar disorder (BD) and comorbid autism spectrum disorder without intellectual disability (ASD-noID), through a comparison with a control group of individuals with BD only. METHODS: We conducted a cross-sectional observational study involving 62 adults with comorbid BD and ASD-noID, recruited at the University Hospital of Pisa between June 2022 and April 2023. Clinical history, psychiatric diagnoses, and symptom profiles were collected using standardized assessment procedures. Group comparisons with a sex-matched control sample of BD patients without ASD were performed. RESULTS: Patients with ASD-BD exhibited an earlier onset of mood symptoms, a higher prevalence of other specified bipolar and related disorder (BD-OS) diagnoses, and greater rates of comorbid anxiety disorders. Temperamental assessment revealed significantly higher scores in cyclothymic, anxious, and depressive dimensions. The ASD-BD group also reported lower global functioning. Finally, ASD-BD individuals show high frequency of adverse reactions to antidepressants and antipsychotics. CONCLUSIONS: BD in adults with ASD-noID presents a distinct clinical phenotype, characterized by atypical mood presentations, emotional dysregulation, complex comorbidity, and reduced treatment tolerability. These findings highlight the importance of improving diagnostic accuracy and adopting personalized treatment approaches for adults with this comorbidity.

Journal of affective disorders, 2026

PMID 41765239

DOI 10.1016/j.jad.2026.121527

This record was extracted from the paper's PubMed abstract and metadata. Full-text methods and risk-of-bias details were not reviewed.